NAMS Updates Position Statement on Menopausal Hormone Therapy

WEDNESDAY, July 20, 2022 (HealthDay News) -- Hormone therapy remains the most effective treatment for vasomotor symptoms (VMS) and genitourinary syndrome of menopause, according to a position statement issued by the North American Menopause Society (NAMS) and published online July 7 in Menopause.
Stephanie S. Faubion, M.D., from the Mayo Clinic in Jacksonville, Florida, and colleagues reviewed the 2017 Position Statement, evaluated new literature, assessed the evidence, and developed updated recommendations on hormone therapy in menopause.
The authors note that hormone therapy remains the most effective treatment for VMS and genitourinary syndrome of menopause and can prevent bone loss and fracture. Risks associated with hormone therapy vary according to factors such as type, dose, duration of use, timing of administration, and whether a progestogen is used. Using the best available evidence, treatment should be individualized to maximize benefits and minimize risks; the benefits and risks of continuing therapy should be evaluated periodically. Low-dose vaginal estrogen therapy or other therapies are recommended for bothersome genitourinary syndrome of menopause symptoms not relieved with over-the-counter therapies in women without indications for use of systemic hormone therapy.
"NAMS is pleased to announce the release of its updated position statement on hormone therapy," Faubion said in a statement. "Since our last position statement on hormone therapy published in 2017, there have been important additions that further clarify the balance of risks and benefits of hormone therapy options for menopause symptoms."
Several authors disclosed financial ties to the pharmaceutical industry.
Related Posts
El ejercicio podría mejorar los resultados de las personas que luchan contra un cáncer de esófago
JUEVES, 3 de febrero de 2022 (HealthDay News) -- Alan Holman no dejó de hacer...
Hepatitis C Can Kill, But Too Many Can’t Access the Cure
THURSDAY, June 29, 2023 (HealthDay News) -- More than 2 million people in the...
Hay un estrecho vínculo entre la segregación y la intoxicación con plomo en los niños afroamericanos
MIÉRCOLES, 30 de agosto de 2023 (HealthDay News) -- Los niños negros pequeños...
Pandemic Disrupted Respiratory Syncytial Virus Season Timing
FRIDAY, April 7, 2023 (HealthDay News) – The typical timing of seasonal...